TAS2R38 is a bitter taste receptor that functions as a G-protein coupled receptor mediating detection of bitter compounds through gustducin-linked signaling 1. The receptor activates downstream pathways involving PLC-β2 and TRPM5 ion channels, enabling perception of bitter taste molecules including phenylthiocarbamide (PTC) and propylthiouracil (PROP) 2. Beyond taste, TAS2R38 plays a broader role in innate immunity, particularly in respiratory defense through nitric oxide-mediated signaling that inhibits pathogen replication 3. Genetically, TAS2R38 exists in two main haplotypes: PAV (proline-alanine-valine), associated with bitter tasting ability, and AVI (alanine-valine-isoleucine), associated with non-tasting phenotype 2. These polymorphisms influence both sensory perception and health outcomes. PAV carriers show protective effects against thyroid dysfunction and reduced consumption of bitter substances like alcohol and horseradish 4, 5. The receptor's expression is regulated by DNA methylation, with altered methylation patterns correlating with SARS-CoV-2 disease severity 3. Clinically, TAS2R38 activation by bitter compounds ameliorates gastroesophageal reflux disease through MAPK/NF-κB pathway suppression and barrier function restoration 1. However, TAS2R38 genotype shows minimal association with gastrointestinal neoplasm risk 6 or chr7 rhinosinusitis 7. The receptor's functional variation may serve as a biomarker for predicting dietary preferences and susceptibility to conditions including obesity and thyroid disease.